• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. BLAKE DRAIN UNKNOWN PRODUCT; CATHETER, IRRIGATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. BLAKE DRAIN UNKNOWN PRODUCT; CATHETER, IRRIGATION Back to Search Results
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Pleural Effusion (2010); Pneumonia (2011); Pneumothorax (2012); Obstruction/Occlusion (2422); Not Applicable (3189)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Citation: journal of laparoscopic and advanced surgical techniques november 2017.Doi: 10.1089/lap.2017.0580.
 
Event Description
Literature article: transhiatal chest drainage after hybrid ivor lewis esophagectomy: proof of concept study.The methods of intercostal pleural drainage after non-cardiac thoracic surgery have been widely debated, but at present, there is no conclusive evidence regarding the optimal tube size, the number of tubes, the threshold for removal, and the need for continuous suction.The authors designed a proof of concept study to test the hypothesis that transhiatal pleural drainage is safe and effective after hybrid ivor lewis esophagectomy.Secondary study outcome was to check for the efficacy of a portable vacuum system connected to the transhiatal drain.It was reported that the main finding of this study is that a transhiatal pleural drain may safely replace the conventional intercostal drain after hybrid ivor lewis esophagectomy.The study consist of 50 patients who underwent a hybrid ivor lewis esophagectomy.The right pleural cavity was drained with a single transhiatal blake tube.A blake transhiatal drain fr 15 was advanced through the 5 mm subxyphoid port into the right pleural cavity until the multichannel segment of the tube was completely inside the chest cavity.The second step of the operation consisted of a right posterior-lateral thoracotomy in the fifth interspace with sparing of the anterior serratus muscle.The active part of the blake drain crossing the hiatus was placed with the tip at the level of the third intercostal space.After complete lung recruitment, the drain was connected to the portable j-vac vacuum drainage system.The system was checked every 3 hours for the first 24 hours to ensure that the bellow was fully charged to guarantee stable lung expansion.The transhiatal drain was connected to the j-vac in all patients at the end of the surgical procedure after lung recruitment.Post-operative complications included left pleural effusion in 9 patients, pneumothorax in 2 patients (required percutaneous catheter drainage), atrial fibrillation in 3 patients, hemothorax in 1 patient (required redo thoracotomy), chyle leakage in 1 patient (required thorascopic duct ligation), anastomotic leak in 1 patient, persistent gastric outlet obstruction possibly related to kinking of the blake drain at the hiatus in 1 patient (required drain removal at the time of the gastrographin swallow study; results showed immediate relief of obstruction), atelectasis in 1 patient, and pneumonia in 1 patient.It was concluded that a pleural drain placed through the upper abdominal port site after hybrid ivor lewis esophagectomy can safely replace the traditional intercostal tube and provide a similar daily fluid output.The transhiatal drainage connected to a j-vac system has also the potential to cause less postoperative discomfort, reduce analgesic requirements, and promote early ambulation and hospital discharge.
 
Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 9/14/2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLAKE DRAIN UNKNOWN PRODUCT
Type of Device
CATHETER, IRRIGATION
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
MDR Report Key7306204
MDR Text Key101268572
Report Number2210968-2018-71116
Device Sequence Number1
Product Code GBX
Combination Product (y/n)N
PMA/PMN Number
CL I EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 02/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received08/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-